|本期目录/Table of Contents|

[1]张世慧,张 燕.影响脓毒症相关急性肾损伤患者 接受连续性肾脏替代治疗的相关因素分析[J].传染病信息,2019,04:341-343.
 ZHANG Shi-hui*,ZHANG Yan.Analysis of factors related to continuous renal replacement therapy in patients with sepsis related acute kidney injury[J].Infectious Disease Information,2019,04:341-343.
点击复制

影响脓毒症相关急性肾损伤患者 接受连续性肾脏替代治疗的相关因素分析(PDF)

《传染病信息》[ISSN:1007-8134/CN:11-3886/R]

期数:
2019年04期
页码:
341-343
栏目:
论著
出版日期:
2019-09-12

文章信息/Info

Title:
Analysis of factors related to continuous renal replacement therapy in patients with sepsis related acute kidney injury
文章编号:
1007-8134(2019)04-0341-04
作者:
张世慧张 燕
610000,成都市第六人民医院肾脏内科(张世慧、张燕)
Author(s):
ZHANG Shi-hui* ZHANG Yan
Department of Nephrology, Chengdu Sixth People’s Hospital, 610000, China
*Corresponding author, E-mail: xingfei3895@163.com
关键词:
脓毒症急性肾损伤连续性肾脏替代治疗相关因素临床指标
Keywords:
sepsis acute kidney injury continuous renal replacement therapy related factors clinical indexes
分类号:
 R692.5;R631.3;R459.5
DOI:
10.3969/j.issn.1007-8134.2019.04.014
文献标识码:
A
摘要:
目的 分析探讨影响脓毒症相关急性肾损伤(acute kidney injury, AKI)患者接受连续性肾脏替代治疗(continuous renal replacement therapy, CRRT)的相关因素。方法 选取我院于2017 年6 月—2018 年12 月间收治的278 例脓毒症相关 AKI 患者为研究对象,根据患者是否选择接受CRRT 将所有患者分为甲、乙2 组,其中甲组为采取CRRT 的患者,乙组则均 为不接受CRRT 的患者。记录2 组患者的临床脏器功能评分和疾病严重程度评分,比较2 组患者的一般资料及实验室检查结 果,对影响患者接受CRRT 的相关危险因素进行Logistic 回归分析。结果 甲组患者的贫血程度重于乙组患者,凝血功能及 肾功能均显著差于乙组患者,B 型钠尿肽和乳酸水平均显著高于乙组患者(P 均< 0.05)。甲组患者的疾病严重程度重于肾 脏、肝脏、肺脏损伤率等均显著高于乙组患者(P 均< 0.05)。Logistic 回归分析结果显示,氧分压、二氧化碳分压、血清 肌酐水平、急性生理与慢性健康评分、ICU 住院时间等因素均是影响患者接受CRRT 的相关危险因素。结论 氧分压、二氧 化碳分压、血清肌酐水平、急性生理与慢性健康评分、ICU 住院时间等均是影响脓毒症相关AKI 患者接受CRRT 的相关因素, 具有较高的临床指导价值。
Abstract:
Objective To analyze the factors influencing the acceptance of continuous renal replacement therapy (CRRT) in septic related acute kidney injury (AKI) patients. Methods From June 2017 to December 2018, 278 patients with septic related AKI admitted in our hospital were included in this study. All the patients were divided into 2 groups (A and B) according to their acceptance of CRRT. The patients in group A received CRRT while those in group B didn’t receive CRRT. Clinical visceral function score and disease severity score of patients in the 2 groups were recorded. General data and laboratory test results of patients in the 2 groups were compared. Logistic regression analysis was conducted on the risk factors related to the acceptance of CRRT in patients. Results The anemia degree, coagulation function and renal function of patients in group A were significantly worse than those of patients in group B, and the levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and lactic acid of patients in group A were significantly higher than those of patients in group B (P < 0.05). The severity of disease and the rate of kidney, liver and lung injury in group A were significantly higher than those in group B (P < 0.05). Logistic regression analysis showed that partial pressure of oxygen, partial pressure of carbon dioxide, serum creatinine level, APACHE Ⅱ score and ICU length of stay were the risk factors influencing the patients receiving CRRT. Conclusions Partial pressure of oxygen, partial pressure of carbon dioxide, serum creatinine level, APACHE Ⅱ score, and ICU length of stay are the risk factors affecting the acceptance of CRRT in patients with septic related AKI, and have great clinical guidance value.  

参考文献/References


[1] 郭东晨,段美丽. 脓毒症相关急性肾损伤连续肾脏替代治疗 危险因素的回顾性分析[J]. 临床和实验医学杂志,2017, 16(20):1996-2000.
[2] 张团结,韩来新,王伟,等. 肝素结合蛋白对脓毒症相关 急性呼吸窘迫综合征的预测价值研究[J]. 传染病信息, 2018,31(1):41-42,47.
[3] Zhou Y, Li P, Goodwin AJ, et al. Exosomes from endothelial progenitor cells improve outcomes of the lipopolysaccharideinduced acute lung injury[J]. Crit Care, 2019, 23(1):44.
[4] 陈玉红,郑明,李斌,等. 不同连续性肾脏替代治疗模式及 其剂量对脓毒症合并急性肾损伤患者溶质清除效果的研究 [J]. 中国全科医学,2016,19(18):2145-2150.
[5] Weidhase L, Wellh?fer D, Schulze G, et al. Is interleukin-6 a better predictor of successful antibiotic therapy than procalcitonin and C-reactive protein? A single center study in critically ill adults [J]. BMC Infect Dis, 2019, 19(1):150.
[6] Khiangte HL, Robinson VL, Veeraraghavan B, et al. Can the imaging manifestations of melioidosis prognosticate the clinical outcome? A 6-year retrospective study[J]. Insights Imaging, 2019, 10(1):17.
[7] 赵晓东,刘红升. 脓毒症性急性肾损伤诊断和预后评估相 关生物标志物的研究进展[J]. 中国全科医学,2016, 19(8):882-885.
[8] 奚希相,李文放,马金苗,等. 尿NGAL 联合MEDS 评分评 估脓毒症合并急性肾损伤患者病情及预后[J]. 第二军医大 学学报,2017,38(2):244-248.
[9] Xue M, Zhang X, Liu F, et al. Effects of chloride content of intravenous crystalloid solutions in critically ill adult patients: a meta-analysis with trial sequential analysis of randomized trial[s J]. Ann Intensive Care, 2019, 9(1):30.
[10] 廖雪莲,康焰. 脓毒症所致急性肾损伤的研究进展[J]. 中 华重症医学电子杂志(网络版),2017,3(4):301-304.
[11] Asai N, Koizumi Y, Yamada A, et al. Pantoea dispersa bacteremia in an immunocompetent patient: a case report and review of the literature[J]. J Med Case Rep, 2019, 13(1):33.
[12] Asai N, Koizumi Y, Yamada A, et al. Pantoea dispersa bacteremia in an immunocompetent patient: a case report and review of the literature[J]. J Med Case Rep, 2019, 13(1):33.
[13] 陈敏华,孙仁华,李茜,等. 脓毒症伴急性肾损伤患者连续 性肾脏替代治疗时机的探讨[J]. 中华危重症医学杂志(电 子版),2016,9(3):149-153.
[14] 戴甜,曹书华,杨晓龙,等. 连续性肾脏替代治疗与间歇性 血液透析对脓毒症急性肾损伤的临床疗效比较[J]. 中华危 重病急救医学,2016,28(3):277-280.
[15] Thompson K, Venkatesh B, Finfer S. Sepsis and septic shock: current approaches to management[J]. Intern Med J, 2019, 49(2):160-170.
[16] Saturno-Hernández PJ, Poblano-Verástegui O, Flores-Hernández S, et al. Quality care indicators for neonates with selected pathologies: pilot study[J]. Salud Publica Mex, 2019, 61(1):35- 45.

备注/Memo

备注/Memo:

[ 通信作者] 张世慧,E-mail: xingfei3895@163.com
更新日期/Last Update: 2019-09-15